TP53 gene mutations and protein accumulation in primary vaginal carcinomas
- 1 July 1995
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 72 (1) , 129-133
- https://doi.org/10.1038/bjc.1995.288
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53Nature, 1993
- Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteriThe Journal of Pathology, 1993
- Detection of point mutations in the p53 gene: Comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniquesHuman Mutation, 1993
- Regulation of the Human hsp70 Promoter by p53Science, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- The p53 tumour suppressor geneNature, 1991
- Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detectionMutation Research Letters, 1991
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989